Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > R+F Revenues and Transaction Bonus

<< Previous

Bullboard Posts

Next >>

Post by Kingkoion Jul 31, 2020 2:29am

269 Views

Post# 31348007

R+F Revenues and Transaction Bonus

Sirona received US$50,000 or CAD$67,225 in royalty payment from R+F and management paid themselves $150,000 and two months before, they gave themselves $110,000 for a total of $260,000. So to recap, $67,225 in revenues and $260,000 in bonuses as follows:
Howard: $94,000
Chris: $74,000
Michelle: $54,000
Graldine: $39,000

How is that even legal? Where is the BCSC?

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects